These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30464373)

  • 41. How can real-world evidence aid decision making during the life cycle of nonprescription medicines?
    Csoke E; Landes S; Francis MJ; Ma L; Teotico Pohlhaus D; Anquez-Traxler C
    Clin Transl Sci; 2022 Jan; 15(1):43-54. PubMed ID: 34405554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proceed with Caution When Using Real World Data and Real World Evidence.
    Kim HS; Kim JH
    J Korean Med Sci; 2019 Jan; 34(4):e28. PubMed ID: 30686950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.
    Timbie JW; Kim AY; Concannon TW
    Value Health; 2021 Dec; 24(12):1792-1798. PubMed ID: 34838277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-world evidence of biological agents in dermatology: A review of its applications, advantages, and limitations.
    Shen J; Liu Y
    Dermatol Ther; 2022 Dec; 35(12):e15909. PubMed ID: 36205394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes.
    O'Donnell JC; Le TK; Dobrin R; Higashi M; Pereira A; Wagner S; Yang A; Hukkelhoven M
    Future Oncol; 2021 Jan; 17(3):333-347. PubMed ID: 33074018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The present and future scope of real-world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future?
    Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 3():21-34. PubMed ID: 32250528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes.
    Patorno E; Schneeweiss S; Wang SV
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 3(Suppl 3):45-59. PubMed ID: 32250527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness analyses using real-world data: an overview of the literature.
    Bowrin K; Briere JB; Levy P; Millier A; Clay E; Toumi M
    J Med Econ; 2019 Jun; 22(6):545-553. PubMed ID: 30816067
    [No Abstract]   [Full Text] [Related]  

  • 50. Real-world evidence research in metastatic colorectal cancer: raising awareness of the need for patient contributions.
    Moss B; Goodall EA; Maravic Z; Marti F; Moss M; Rowley S; Sarrauste C; Wheatstone P
    Future Oncol; 2023 Aug; 19(26):1809-1821. PubMed ID: 37439564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits and limitations of real-world evidence: lessons from
    Nazha B; Yang JC; Owonikoko TK
    Future Oncol; 2021 Mar; 17(8):965-977. PubMed ID: 33242257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.
    Schneeweiss S; Patorno E
    Endocr Rev; 2021 Sep; 42(5):658-690. PubMed ID: 33710268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-world evidence use in assessments of cancer drugs by NICE.
    Bullement A; Podkonjak T; Robinson MJ; Benson E; Selby R; Hatswell AJ; Shields GE
    Int J Technol Assess Health Care; 2020 Jul; ():1-7. PubMed ID: 32646531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Big data and real-world data-based medicine in the management of hypertension.
    Okada M
    Hypertens Res; 2021 Feb; 44(2):147-153. PubMed ID: 33250517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives.
    Clausen M; Mighton C; Kiflen R; Sebastian A; Dai WF; Mercer RE; Beca JM; Isaranuwatchai W; Chan KKW; Bombard Y
    CMAJ Open; 2020; 8(4):E772-E778. PubMed ID: 33234584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-World Evidence in the Real World: Beyond the FDA.
    Krause JH; Saver RS
    Am J Law Med; 2018 May; 44(2-3):161-179. PubMed ID: 30106647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-world evidence in diabetes: relevance to clinical practice.
    Blonde L; Bailey T; Strong J; Levin P
    J Fam Pract; 2019 Apr; 68(3 Suppl):. PubMed ID: 31219479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCE.
    Oehrlein EM; Graff JS; Perfetto EM; Mullins CD; Dubois RW; Anyanwu C; Onukwugha E
    Int J Technol Assess Health Care; 2018 Jan; 34(1):111-119. PubMed ID: 29415784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
    Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB
    Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
    Malone DC; Brown M; Hurwitz JT; Peters L; Graff JS
    Value Health; 2018 Mar; 21(3):326-333. PubMed ID: 29566840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.